Skip to content
lifestyle.smarttalksuccess.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
OSR Health, Inc.
Vaximm AG, an OSR Company, Announces Forthcoming Publication of Cross-Indication Clinical Data for VXM01, Its VEGFR-2-Targeted Cancer Vaccine Platform
August 3, 2026
OSR Health Secures Nasdaq Communication: Loyalty CVR Program Will Not Trigger a Price Adjustment
July 31, 2026
OSR Health Announces Shareholder Loyalty Program to Reward Conviction Holders With Additional Shares
June 25, 2026
OSR Holdings Is Now OSR Health – A New Name That Says Exactly What We Do
June 22, 2026